|
|
||||||||
Ann Thorac Surg 2003;75:1842-1848
© 2003 The Society of Thoracic Surgeons
a Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
* Address reprint requests to Dr Moon, Division of Cardiothoracic Surgery, Queeny Tower, Suite 3108, One Barnes-Jewish Hospital Plaza, St. Louis, Missouri 63110-1013, USA.
e-mail: moonm{at}msnotes.wustl.edu
Presented at the Forty-ninth Annual Meeting of the Southern Thoracic Surgical Association, Miami, FL, Nov 79, 2002.
BACKGROUND: The purpose of the this investigation was to assess postoperative survival and quality of life with transmyocardial laser revascularization (TMR) in high-risk patients.
METHODS: During a 24-month period, 81 consecutive patients underwent either sole therapy TMR (n = 34) or TMR with coronary artery bypass grafting (n = 47) using a holmium:yttriumaluminumgarnet (YAG) laser. Outcomes were assessed in three high-risk groups, including patients with left ventricular dysfunction (ejection fraction ≤ 0.40) (n = 37), unstable angina (n = 30), and congestive heart failure (n = 33). Disease-specific quality of life was assessed using the Seattle Angina Questionnaire in 58 late survivors and compared with an age-matched cohort undergoing coronary artery bypass grafting only (no TMR) (n = 20).
RESULTS: Overall mortality was 6% ± 3% (±70% confidence limit) and appeared higher with left ventricular dysfunction (11% ± 5% vs 2% ± 2%), but the difference did not reach statistical significance (p = 0.17; power = 0.16). There was also no statistical difference with unstable angina (10% ± 6% vs 4% ± 3%; p > 0.53) or congestive failure (9% ± 5% vs 4% ± 3%; p > 0.66). However, survival at 18 months was significantly lower with left ventricular dysfunction (62% ± 9% vs 90% ± 5%; p < 0.003) and congestive failure (48% ± 10% vs 96% ± 3%; p < 0.001). For sole therapy TMR, quality of life was diminished comparing TMR with coronary artery bypass grafting (p < 0.004) and coronary artery bypass grafting only (p < 0.002).
CONCLUSIONS: Transmyocardial laser revascularization can be performed in high-risk patients, but survival is significantly impaired in patients with left ventricular dysfunction and congestive failure, and quality of life is diminished without some degree of direct revascularization.
This article has been cited by other articles:
![]() |
D. D. Yuh, B. A. Simon, A. Fernandez-Bustamante, N. Ramey, and W. A. Baumgartner Totally endoscopic robot-assisted transmyocardial revascularization J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 120 - 124. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |